Entwicklung neuartiger Targeted Therapy-Strategien zur Behandlung des chemotherapieresistenten Ovarialkarzinoms unter besonderer Berücksichtigung von Histondeacetylase-Inhibitoren
- Alternative title
-
Development of novel targeted therapy strategies for the treatment of chemotherapy-resistant ovarian cancer with special focus on histone deacetylase inhibitors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
Düsseldorf, Heinrich-Heine-Universität, Dissertation, 2021
- Keyword
- Event
-
Veröffentlichung
- (where)
-
Düsseldorf
- (who)
-
Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
- (when)
-
2021
- Creator
- Contributor
-
Kassack, Matthias
Fehm, Tanja
- URN
-
urn:nbn:de:hbz:061-20210709-131827-4
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
13.03.2023, 1:55 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bandolik, Jan Josef
- Kassack, Matthias
- Fehm, Tanja
- Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
Time of origin
- 2021
Other Objects (12)
Targeted therapy of neuroblastoma with HDAC8 inhibitor and ALK inhibitor
Quantitative proteomic investigation of enzyme inhibitors for targeted therapy
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
Targeted cancer therapy
Targeted Therapy beim Nierenzellkarzinom
Advances in targeted cancer therapy
Targeted Therapy in der Rheumatologie
Signal transduction and targeted therapy
Successes and limitations of targeted cancer therapy
Karzinogenese des Ovarialkarzinoms
Darstellung neuartiger Inhibitoren der Proteinbiosynthese
Entry inhibitors in HIV therapy
Targeted therapy of neuroblastoma with HDAC8 inhibitor and ALK inhibitor
Quantitative proteomic investigation of enzyme inhibitors for targeted therapy
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
Targeted cancer therapy
Targeted Therapy beim Nierenzellkarzinom
Advances in targeted cancer therapy
Targeted Therapy in der Rheumatologie
Signal transduction and targeted therapy
Successes and limitations of targeted cancer therapy
Karzinogenese des Ovarialkarzinoms
Darstellung neuartiger Inhibitoren der Proteinbiosynthese
Entry inhibitors in HIV therapy
Targeted therapy of neuroblastoma with HDAC8 inhibitor and ALK inhibitor
Quantitative proteomic investigation of enzyme inhibitors for targeted therapy
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
Targeted cancer therapy
Targeted Therapy beim Nierenzellkarzinom
Advances in targeted cancer therapy
Targeted Therapy in der Rheumatologie
Signal transduction and targeted therapy
Successes and limitations of targeted cancer therapy
Karzinogenese des Ovarialkarzinoms
Darstellung neuartiger Inhibitoren der Proteinbiosynthese